At NXT QST FWD we enable large molecule innovation and accelerate Biomanufacturing at scale by delivering advanced, customizable environments tailored to the unique needs of the sector.
With a visionary approach to creating science environments, NXT QST FWD is redefining the landscape of scientific research and manufacturing in India. Our offerings include:
- Modular and built-to-suit lab and biomanufacturing spaces
- Turnkey fit-out solutions and 24/7 expert operational support
We engineer next-generation infrastructure: powering today’s capabilities while unlocking tomorrow’s scientific advancements. We are committed to building a future where India leads in scientific discovery and biomanufacturing excellence.
Cell and Gene Therapy: Specialized Infrastructure for Advanced Therapeutics
Cell and gene therapies represent a transformative frontier in large molecules, requiring ultra-specialized processing environments, strict environmental control, and cleanroom precision. We support companies developing advanced therapeutics by offering highly configurable infrastructure that facilitates biocontainment protocols and alignment with regulatory standards for cell processing and genetic vector development.
Vaccine & Biosimilar Manufacturing: Infrastructure for Reliable Production
The rapid scaling and production of vaccines and biosimilars demand reliable batch consistency, robust quality assurance systems, and high-capacity processing setups. Our specialized facilities offer the seamless transition environments need to seamlessly navigate strain development, scale-up, and regulatory validation to meet global and domestic market demands.
Genomics, Microbiome & Diagnostics: Empowering High-Precision Workflows
At NXT QST FWD, we empower genomics and microbiome research companies across India with advanced core laboratories equipped for high-throughput sequencing, bioinformatics, and diagnostic test development. Our integrated infrastructure supports high-precision biological workflows, secure data platforms complying with localization rules, and the commercialization of diagnostic platforms, including indigenous CRISPR-based diagnostic kits.
Precision Fermentation: Bridging Synthetic Bio Discovery and Commercial Scale
Scaling synthetic biology innovations relies heavily on high-precision fermentation and bioprocess technology. We offer flexible biomanufacturing spaces that host microbial, fungal, and precision fermentation setups, giving companies the necessary utility support, gas lines, and waste management infrastructure to move smoothly from bench-scale validation to bulk commercial yields.
Infrastructure for Innovation
At NXT QST FWD, we empower life science innovators with modular, future-ready R&D infrastructure spanning from 5,000 sq. ft. to 50,000 sq. ft. As biologics and large-molecule modalities move from discovery into development, our labspaces are purpose-designed around biosafety, containment, environmental control, and strict regulatory expectations.
Our labspaces are engineered to host GLP environments, BSL-2/BSL-3 laboratories, and ISO 14644-classified cleanrooms—a critical requirement for high-precision large molecule research. These specialized environments are supported by suitable space segregation, tailored high-side HVAC, and critical utilities suited to biologics research, process and analytical development, and microbiology.
Our labspaces are designed to support ISO/IEC 17025 accreditation and NABL standards across a range of testing scopes, our automated reporting platforms generate instant, audit-ready data logs that streamline compliance, reduce manual intervention, and cut compliance-related incidents by 30% within the first year of deployment.
Infrastructure for Biomanufacturing
For companies transitioning from clinical supply to full-scale commercial manufacturing, We deliver scalable biomanufacturing infrastructure ranging from 20,000 sq. ft. to 200,000 sq. ft. Designed around the stringent infrastructure and quality requirements of GMP operations, our biomanufacturing spaces are designed to support classified processing environments, validated systems, controlled personnel and material flows, and utility systems aligned to applicable US FDA cGMP, EU GMP, and WHO GMP standards.
Our infrastructure enables seamless pilot-to-scale transition, and supports in-process, release, and stability testing while accelerating regulatory alignment with CDSCO, ICMR, and international regulatory frameworks.
NXT QST FWD: Setting New Standards in Science Infrastructure
In India’s rapidly evolving scientific landscape, we deliver high-impact, sustainable, and reliable infrastructure:
- 80% Faster Activation: Lab and facility buildouts 80% faster than traditional industry timelines, allowing organizations to accelerate research schedules and reach market faster.
- 30% Lower Resource and Energy Consumption: Built with advanced green building technologies and energy-efficient systems, our facilities achieve over 30% reduction in resource and energy consumption.
- 100% Discharge Treated: Operating with a complete focus on environmental responsibility, our campuses feature zero liquid discharge (ZLD) integration.
- 100% Operational Uptime: Uninterrupted research and production workflows backed by utility redundancies, continuous real-time monitoring and maintenance.
Central to our model is an integrated science cluster framework—co-locating advanced R&D and biomanufacturing, analytics, and essential support services. Over two decades, we have partnered with over 75 scientific enterprises and facilitated the successful launch and commercialization of biological products globally.
Future Outlook
As India’s bioeconomy and large molecules sector accelerates, we at NXT QST FWD are charting an ambitious roadmap to expand our science infrastructure footprint to 5 million sq. ft. by 2030. This strategy is underpinned by continuous investments in advanced design and tech integration, sustainable infrastructure and collaborative ecosystems.